Is Curative Biotechnology, Inc. (CUBT) a Buy, Sell, or Hold?
OTC : CUBT
Curative Biotechnology, Inc.
$1 USD
$0 (0.0%)
- Volume
- 320
- Average Volume
- 1.44K
- Market Capitalization
- $6.82M
- P/E Ratio
- -2.81
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.99
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
| Source | Headline |
|---|---|
|
Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement
PennVet Study to Evaluate GMP-Grade Metformin Eye Drops in a Canine Model Supporting Human and Veterinary Development Pathways Palm Beach Gardens, FL, May 07, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Company"), a development-stage biomedical company focused on novel therapies for degenerative eye diseases, today announced that it has entered into a Sponsored Research Agreement with the University of Pennsylvania's School of Veterinary Medicine ("PennVet") to support a K9 study evaluating its metformin-based topical ophthalmic formulation (eye drops). globenewswire.com - 2026-05-07 07:00:00 |
